Showing results (371-380 of 481) with videos related to
Sort By:
Pageof 49
Blood|July 3, 2009
Mutations in CBL occur frequently in juvenile myelomonocytic leukemiaMignon L Loh, Debbie S Sakai, Christian Flotho, et al.Nature Communications|July 31, 2019
A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunityJoshua D Ooi, Jhih-Hang Jiang, Peter J Eggenhuizen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232Eric C Larsen, Meenakshi Devidas, Si Chen, et al.Blood|June 18, 2011
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology GroupJinghui Zhang, Charles G Mullighan, Richard C Harvey, et al.Leukemia|February 24, 2018
Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG)Sumit Gupta, Meenakshi Devidas, Mignon L Loh, et al.Clinical Nephrology|February 19, 2021
Evolution of IgA nephropathy in Singapore over four decades and a comparison of two cohorts from the first and fourth decadeKeng Thye Woo, Choong Meng Chan, Marjorie Foo, et al.Blood|August 6, 2005
The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemiaRoss L Levine, Marc Loriaux, Brian J P Huntly, et al.Blood Advances|January 26, 2021
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemiaAnjali S Advani, Eric Larsen, Kristina Laumann, et al.JAMA Oncology|January 27, 2022
Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic LeukemiaShawn H R Lee, Federico Antillon-Klussmann, Deqing Pei, et al.Pediatric Blood & Cancer|March 10, 2025
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaAndrew E Place, Seth E Karol, Christopher J Forlenza, et al.Pageof 49